Anxiety Disorders Withdrawn Phase 4 Trials for Buspirone (DB00490)

Also known as: Anxiety Disorder / Anxiety NOS

IndicationStatusPhase
DBCOND0027904 (Anxiety Disorders)Withdrawn4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01546896Effects of Buspar on Depressive Symptom Improvement and Neuroprotection in Patients With Anxiety DisorderTreatment